PlainRecalls

Martin Avenue Pharmacy, Inc.

Compiled from official public sources by the publisher.

118 recalls on record · Latest: Nov 5, 2014

Subscribe to new Martin Avenue Pharmacy, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Martin Avenue Pharmacy, Inc. HEAVY-BOOK · SINGLE-AGENCY

#134 of 14,151 · 118 notices · 0.113% archive

  • BOOK 118 notices
  • RANK #134 of 14,151
  • SHARE 0.113% archive
  • AGENCY FDA Drug (118)
  • CAT drugs
  • CATS 3 categories
  • LATEST Nov 5, 2014
  • PHOTO Assurance Infusion

Nearest notice-volume peer: Assurance Infusion (0 notice gap)

Martin Avenue Pharmacy, Inc. accounts for about 0.113% of the 104,423-notice archive on 118 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Martin Avenue Pharmacy, Inc. compares to 14,151 recalling firms

Martin Avenue Pharmacy, Inc. ranks 134th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Martin Avenue Pharmacy, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

118 134th of 14151 higher than 14,016 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Martin Avenue Pharmacy, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Martin Avenue Pharmacy, Inc. holds about 0.113% of archive notices alongside 118 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Nov 5, 2014

Pilocarpine (PF) 0.25% opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Chlorhexidine gluconate 0.02% opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Cefazolin forte 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Histamine 2.75 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Cyclosporine/corn oil stock vehicle oil packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Calcium chloride (PF) 100 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Tri-mix T25, 4.413 mg/0.145 mg/1.475 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Hydromorphone/bupivacaine (PF) 0.5 mg/0.2 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Sodium tetradecyl sulfate 2% (PF) injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Triamcinolone acetonide (PF) 40 mg/mL injection suspension packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Bupivacaine hydrochloride 0.25% injectable packaged in an amber glass injectable vial,Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Tri-mix T106, 30 mg/1 mg/25 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Bacteriostatic water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Tri-mix, 15 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Fentanyl/bupivacaine 3000 mcg/30 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Nalbuphine 10 mg/mL injection solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
FDA Drug Moderate Nov 5, 2014

Dihydroergotamine mesylate 1 mg/mL injection solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

Martin Avenue Pharmacy, Inc. carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (118 here — heavy-book).

Assurance Infusion 118 Porsche 118 C.r. Bard Inc 117 Snoqualmie Gourmet Ice Cream 117 Elekta, Inc. 116

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Lupin Pharmaceuticals Inc. 122 Pfizer Inc. 123 Krs Global Biotechnology, Inc 129 Sca Pharmaceuticals 107

Frequently Asked Questions

How many federal recall notices name Martin Avenue Pharmacy, Inc.? ▼
PlainRecalls indexes 118 distinct federal recall events naming Martin Avenue Pharmacy, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Martin Avenue Pharmacy, Inc. sit among other recalling firms? ▼
Martin Avenue Pharmacy, Inc. ranks #134 of 14,151 by distinct recall-event count among 14,151 firms in this archive (99th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Martin Avenue Pharmacy, Inc.'s notices? ▼
FDA Drug accounts for 118 of this firm's 118 indexed notices.
What product category dominates Martin Avenue Pharmacy, Inc.'s filing book? ▼
Filings for Martin Avenue Pharmacy, Inc. span 3 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Martin Avenue Pharmacy, Inc.: 118 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Martin Avenue Pharmacy, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026